Authors:
Mizuno, M
Nishikawa, K
Spiller, OB
Morgan, BP
Okada, N
Okada, H
Matsuo, S
Citation: M. Mizuno et al., Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats, ARTH RHEUM, 44(10), 2001, pp. 2425-2434
Authors:
Spiller, OB
Goodfellow, IG
Evans, DJ
Almond, JW
Morgan, BP
Citation: Ob. Spiller et al., Echoviruses and Coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF, J INFEC DIS, 181(1), 2000, pp. 340-343
Authors:
Goodfellow, IG
Powell, RM
Ward, T
Spiller, OB
Almond, JW
Evans, DJ
Citation: Ig. Goodfellow et al., Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum tothe complement control protein CD59, J GEN VIROL, 81, 2000, pp. 1393-1401
Citation: Cl. Harris et al., Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities, IMMUNOLOGY, 100(4), 2000, pp. 462-470
Authors:
Spiller, OB
Criado-Garcia, O
De Cordoba, SR
Morgan, BP
Citation: Ob. Spiller et al., Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack, CLIN EXP IM, 121(2), 2000, pp. 234-241
Authors:
McGrath, Y
Wilkinson, GWG
Spiller, OB
Morgan, BP
Citation: Y. Mcgrath et al., Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases, J IMMUNOL, 163(12), 1999, pp. 6834-6840
Citation: Ob. Spiller et al., Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells, J IMMUNOL M, 224(1-2), 1999, pp. 51-60
Citation: Ob. Spiller et Pb. Morgan, Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts, J INFEC DIS, 178(6), 1998, pp. 1597-1603